Article

Comparative proteomic analysis of low stage and high stage endometrioid ovarian adenocarcinomas.

2008-04-01

Abstract excerpt

Ovarian cancer, the second most common gynecological malignancy, accounts for 3% of all cancers among women in the United States, and has a high mortality rate, largely because existing therapies for widespread disease are rarely curative. Ovarian endometrioid adenocarcinoma (OEA) accounts for about 20% of the overall incidence of all ovarian cancer. We have used proteomics profiling to characterize low stage (FIG...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3c83b150-8ef2-5ec7-b7a8-cc77233d271a
DOI: 10.1002/prca.200780004

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comparative proteomic analysis of low stage and high stage endometrioid ovarian adenocarcinomas.DOI 10.1002/prca.200780004Read

Differential Protein Mapping of Ovarian Serous Adenocarcinomas: Identification of Potential Markers for Distinct Tumor StageSemantic proximity Read

Comparative proteome analysis of human epithelial ovarian cancerSemantic proximity Read

Proteomic characterization of epithelial ovarian cancer delineates molecular signatures and therapeutic targets in distinct histological subtypesSemantic proximity Read

Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional statusSemantic proximity Read

Applications of Proteomics in Ovarian Cancer: Dawn of a New EraSemantic proximity Read

Unraveling endometriosis-associated ovarian carcinomas using integrative proteomicsSemantic proximity Read

Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysis.Semantic proximity Read

Expression Profiling of Serous Low Malignant Potential, Low-Grade, and High-Grade Tumors of the OvarySemantic proximity Read

Deep plasma proteomics identifies and validates an eight-protein biomarker panel that separate benign from malignant tumors in ovarian cancerSemantic proximity Read

Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomicsSemantic proximity Read

Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.Semantic proximity Read

Phenotypic analysis of ovarian carcinoma: polypeptide expression in benign, borderline and malignant tumors.Semantic proximity Read